Blog

390 Startup Failure Post-Mortems

Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using Insilico's Proprietary End-to-end Artificial Intelligence Platform

How AI Is Aiming at the Bad Math of Drug Development

The bright new age of venture capital

Medical tech again tops Deloitte’s technology 500 rankings

Collaboration is key as biopharma firms speed up their response to demands for innovation

EU tries on new role as tech venture capitalist

Family offices become serious rivals to VC firms for funding start-ups

AI software market set to reach new heights next year

Dangers of unregulated artificial intelligence

AI, ML, cloud, 5G to be most important technologies in 2022: Study

FDA Joins Other Regulators in Focus on AI and Machine Learning

What Will the Effect of Europe's AI Law Be on Tech Companies?

5 Best Practices for Testing AI Applications

Breakthrough science and the future of venture capital

Top 10 Emerging Technologies of 2021

Artificial Intelligence In Drug Discovery

Investment Into Biosciences Boomed With COVID, But Could The Bubble Burst?

AI startups notched another big quarter in a record-breaking year for global funding, mega-rounds, unicorns, exits, and more.

Cerebras Systems Raises $250M in Funding for Over $4B Valuation to Advance the Future of Artificial Intelligence Compute

Accenture’s Julie Sweet: A.I. can transform companies, creating ‘responsibility and possibility’ for CEOs

French AI strategy: Tech sector to receive over €2 bln in next 5 years

Biden's top science advisor working on AI Bill of Rights

Accenture (ACN) Announces Strategic Investment in Geneyx

Filings buzz in pharmaceuticals: 24% increase in artificial intelligence mentions in Q2 2021

CapitalVX: A machine learning model for startup selection and exit prediction

Google’s New Company Will Discover Medicines Via Artificial Intelligence & Save Lives

Is AI delivering on the hype?

AWS Snatches Growth-Rate Momentum from Microsoft, Cites Machine Learning

Pandemic has caused perfect storm for MedTech

Cambridge-1 and the future of medicine

Four major impacts of artificial intelligence on healthcare

AI could exacerbate inequalities if misapplied, healthcare sector warned

Our Relationship with AI: Friend Or Foe? Summary of our Global Study

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Artificial Intelligence Is Transforming Biotechnology, Especially When It Comes To Innovations In Nitric Oxide

Predictive language models' underlying function more closely resembles the human brain

How data is helping European VCs find their next hidden gems

Big-name U.S. tech investors are moving in on Europe in increasing numbers

Alpha Connector - Robert Marcus - Founder, and CEO of Alpha10X

Venture capital firm Sofinnova raises 472 mln euros to focus on healthcare start-ups

Gartner Identifies the Top Strategic Technology Trends for 2022

Gartner survey of CIOs highlights investments in AI, cloud and cybersecurity

The Source Code of Life

The 2021 machine learning, AI, and data landscape

AI’s Smarts Now Come With a Big Price Tag

Broad Institute, Intel, Google Advance Biomedical Research

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

With the Metaverse on the way, an AI Bill of Rights is urgent

What’s big in A.I. this year

Microsoft’s next moves: Biz dev and strategy leader Christopher Young is focusing on these key areas

Emmanuel Macron unveils a €30 billion plan to create France's 'high tech champions of the future'

European Biotech Investors Cap Off Record Year in Fundraising

DeepMind is developing one algorithm to rule them all

Amazon Genomics CLI is Open Source, UK Biobank’s Research Analysis Platform Live

New records were set in a huge quarter for global & US funding, exits, valuations, and more.

UBS clients raise $650 mln for biggest yet biotech impact fund

Google’s DeepMind turns first profit as revenues soar

Reportable Launches Media Monitoring Service for Biotech, Medical Device and Pharmaceutical Companies

The Coming Age for Tech x Bio: The “Industrial Bio Complex”

Global data and analysis on dealmaking, funding, and exits in private-market companies

The State of Venture

Government to nurture AI-specializing medical scientists

Vietnam Accelerates Investment in Artificial Intelligence

Drug discovery platform Exscientia sets terms for $275 million US IPO

Platform that Offers AI Investment Advice MDOTM Raises €6.2 million Series B, Currently holds € 750 million AUA

The Unicorn Report: Visualizing The Increasingly Crowded Billion-Dollar Company Club

Arabesque launches the world’s first AI-powered ESG portfolio manager

Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

New ten-year plan to make Britain global AI superpower

Intuit launches venture arm to invest in startups with innovation for small businesses, consumers

UK life science attracts £850m deal

Artificial intelligence a key challenge for Germany's next government

Venture capitalists raise more than $100bn to target life sciences

Jeito extends global reach in oversubscribed $625M venture fund

China's industrial heartland embraces artificial intelligence

Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report

Federated learning for predicting clinical outcomes in patients with COVID-19

How AI simplifies data management for drug discovery

Exscientia Files For $100M IPO

Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology

Women less likely to win major research awards

Harnessing artificial intelligence to help prevent epidemics before they spread

Gates Foundation pours cash into British firm Exscientia to fight pandemics

Tough Tech Landscape

Carnegie Mellon University and Emerald Cloud Lab to Build World's First University Cloud Lab

Why AI is so difficult to apply in finance

AI breakthrough could spark medical revolution

AI and the Global Economic Pivot to Sustainability

The Heart of AI

Chamath Palihapitiya – Venture Capital – Silicon Valley Ponzi Scheme

Discovering the next unicorn founder with data, not gut instinct

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Why venture capital should be treated as a science not as an art

Ronald Cohen: “Mesurons l’impact comme on mesure les profits”

VC Firms Have Long Backed AI. Now, They Are Using It.

Bridging the ESG Valley of Death

Gartner: 75% of VCs will use AI to make investment decisions by 2025

These are the biggest trends in clean tech in 2021

Venture Investors Turn To AI To Find Deal

390 Startup Failure Post-Mortems

The bright new age of venture capital

Collaboration is key as biopharma firms speed up their response to demands for innovation

EU tries on new role as tech venture capitalist

Family offices become serious rivals to VC firms for funding start-ups

AI software market set to reach new heights next year

What Will the Effect of Europe's AI Law Be on Tech Companies?

Investment Into Biosciences Boomed With COVID, But Could The Bubble Burst?

AI startups notched another big quarter in a record-breaking year for global funding, mega-rounds, unicorns, exits, and more.

Cerebras Systems Raises $250M in Funding for Over $4B Valuation to Advance the Future of Artificial Intelligence Compute

Accenture’s Julie Sweet: A.I. can transform companies, creating ‘responsibility and possibility’ for CEOs

French AI strategy: Tech sector to receive over €2 bln in next 5 years

Accenture (ACN) Announces Strategic Investment in Geneyx

CapitalVX: A machine learning model for startup selection and exit prediction

How data is helping European VCs find their next hidden gems

Big-name U.S. tech investors are moving in on Europe in increasing numbers

Venture capital firm Sofinnova raises 472 mln euros to focus on healthcare start-ups

Gartner survey of CIOs highlights investments in AI, cloud and cybersecurity

The 2021 machine learning, AI, and data landscape

AI’s Smarts Now Come With a Big Price Tag

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Emmanuel Macron unveils a €30 billion plan to create France's 'high tech champions of the future'

European Biotech Investors Cap Off Record Year in Fundraising

Amazon Genomics CLI is Open Source, UK Biobank’s Research Analysis Platform Live

New records were set in a huge quarter for global & US funding, exits, valuations, and more.

UBS clients raise $650 mln for biggest yet biotech impact fund

Google’s DeepMind turns first profit as revenues soar

Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care

Global data and analysis on dealmaking, funding, and exits in private-market companies

Government to nurture AI-specializing medical scientists

Vietnam Accelerates Investment in Artificial Intelligence

Drug discovery platform Exscientia sets terms for $275 million US IPO

Platform that Offers AI Investment Advice MDOTM Raises €6.2 million Series B, Currently holds € 750 million AUA

The Unicorn Report: Visualizing The Increasingly Crowded Billion-Dollar Company Club

Arabesque launches the world’s first AI-powered ESG portfolio manager

Intuit launches venture arm to invest in startups with innovation for small businesses, consumers

Interest in sustainable investing is at an all-time high

UK life science attracts £850m deal

Artificial intelligence a key challenge for Germany's next government

Venture capitalists raise more than $100bn to target life sciences

Jeito extends global reach in oversubscribed $625M venture fund

China's industrial heartland embraces artificial intelligence

Exscientia Files For $100M IPO

Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology

Gates Foundation pours cash into British firm Exscientia to fight pandemics

Tough Tech Landscape

Why AI is so difficult to apply in finance

The Heart of AI

Chamath Palihapitiya – Venture Capital – Silicon Valley Ponzi Scheme

Discovering the next unicorn founder with data, not gut instinct

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Why venture capital should be treated as a science not as an art

Ronald Cohen: “Mesurons l’impact comme on mesure les profits”

VC Firms Have Long Backed AI. Now, They Are Using It.

Bridging the ESG Valley of Death

Do Algorithms Make Better and Fairer Investments Than Angel Investors?

Gartner: 75% of VCs will use AI to make investment decisions by 2025

These are the biggest trends in clean tech in 2021

Major venture capital investment in European life sciences will fuel occupier market

How AI Is Aiming at the Bad Math of Drug Development

Biden's top science advisor working on AI Bill of Rights

Filings buzz in pharmaceuticals: 24% increase in artificial intelligence mentions in Q2 2021

Our Relationship with AI: Friend Or Foe? Summary of our Global Study

Alpha Connector - Robert Marcus - Founder, and CEO of Alpha10X

Reportable Launches Media Monitoring Service for Biotech, Medical Device and Pharmaceutical Companies

The Unicorn Report: Visualizing The Increasingly Crowded Billion-Dollar Company Club

Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report

Women less likely to win major research awards

How AI Is Aiming at the Bad Math of Drug Development

Biden's top science advisor working on AI Bill of Rights

Filings buzz in pharmaceuticals: 24% increase in artificial intelligence mentions in Q2 2021

Our Relationship with AI: Friend Or Foe? Summary of our Global Study

Alpha Connector - Robert Marcus - Founder, and CEO of Alpha10X

Reportable Launches Media Monitoring Service for Biotech, Medical Device and Pharmaceutical Companies

The Unicorn Report: Visualizing The Increasingly Crowded Billion-Dollar Company Club

Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report

Women less likely to win major research awards